Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Placebo Controlled, Double-blind, Parallel Group, Dose-finding Phase 2 Study to Evaluate the Efficacy and Safety of BAY 2433334 in Patients Following an Acute Myocardial Infarction

NCT04304534 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04304534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04304534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Placebo Controlled, Double-blind, Parallel Group, Dose-finding Phase 2 Study to Evaluate the Efficacy and Safety of BAY 2433334 in Patients Following an Acute Myocardial Infarction
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
June 17, 2020
Completion date
February 21, 2022
Enrollment
1,601 (actual)
Sites
160

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction